PubMed:24691501 / 0-115
Annnotations
c_corpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 18-28 | SO:1000009 | denotes | transition |
| T4 | 32-56 | D002285 | denotes | ductal carcinoma in situ |
| T5 | 32-56 | D002285 | denotes | ductal carcinoma in situ |
| T10 | 69-85 | D044584 | denotes | ductal carcinoma |
| T11 | 69-85 | D044584 | denotes | ductal carcinoma |
| T14 | 91-97 | CVCL_E024 | denotes | Gemini |
| T18 | 98-107 | 11253 | denotes | vitamin D |
| T16 | 98-107 | CHEBI:89324 | denotes | vitamin D |
| T17 | 98-107 | D014807 | denotes | vitamin D |
| T19 | 98-107 | D014807 | denotes | vitamin D |
| T20 | 98-107 | CHEBI:27300 | denotes | vitamin D |
UseCases_ArguminSci_Discourse
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-115 | DRI_Background | denotes | Inhibition of the transition of ductal carcinoma in situ to invasive ductal carcinoma by a Gemini vitamin D analog. |